Rare diseases
Investigational molecules
Locations
Back to Italy2 655 clinical trials in Varese, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A Study of Disitamab Vedotin for Adults with HER2 Expressing Advanced Breast Cancer
ItalyA Study of ALXN1920 Compared to Placebo in Adults with Primary Membranous Nephropathy at High Risk for Disease Progression
ItalyA Study of GSK4524101 and Niraparib for Adults with Advanced Solid Tumors or Metastatic Breast Cancer with BRCA Gene Changes
ItalyA study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease
ItalyA Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer's Disease
ItalyA study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer
ItalyA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
ItalyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
ItalyStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
ItalyStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
ItalyStudy of radiotherapy with durvalumab and ceralasertib in patients with stage III non-small cell lung cancer who have thoracic relapse after PACIFIC treatment
ItalyStudy of ultevursen treatment in patients with retinitis pigmentosa caused by mutations in USH2A gene exon 13
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood cancers and lymphomas, including studies of novel therapies for acute myeloid leukemia and chronic myeloid leukemia. Clinical trials are evaluating innovative treatment combinations and maintenance strategies.
Investigations include maintenance therapies and comparison of shortened versus standard chemotherapy protocols combined with immunotherapy.
Comprehensive studies on non-small cell lung cancer and pleural mesothelioma, exploring innovative combination therapies and targeted treatments for specific genetic mutations.
Research focuses on personalized treatment approaches and novel drug combinations to improve patient outcomes.
Advanced research in cardiovascular disease and thrombosis, with trials examining innovative treatments for reducing cardiovascular events and managing blood clots.
Studies aim to evaluate new therapeutic approaches for preventing major cardiovascular events and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
